* 中国生物科技公司--诺诚健华港股9969.HK周五早盘高开13.6%，目前升幅收窄；其A股688428.SS亦一度升11.7%。
* 该公司此前公告称，预计2025年度首次实现扭亏为盈，净利润约6.33亿元人民币，主要因为药品总销售收入实现快速增长、商务拓展（BD）收入增长。
* 诺诚健华A股今年迄今涨4.4%，同期沪深300指数.CSI300上扬1.6%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 吴云凌)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.